- Category
- Micro (2024-25)
- Udyam number
- UDYAM-KR-03-0212737

Cyto-Sure Private Limited
About Cyto-Sure Private Limited
Data last updated:
Cyto-Sure Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 26 December 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U85300KA2018PTC119784. Its GSTIN is 29AAHCC9291P1ZN (Karnataka).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Gopal Sudershan Reddy and Kalavati Sudershan Reddy.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at No.1796 21st Cross C Block 5th Main Sahakaranagar, Bangalore, Karnataka, India – 560092.
As per the financials filed for FY 2022, the company reported a revenue of ₹35,400. For the same year it recorded a net loss of ₹43,900 (net margin -124%) and EBITDA of -₹43,900 (EBITDA margin -124%).
As per MCA filings, the company has open charges of ₹23 Lakh on record.
Cyto-Sure Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0212737).
Company details
Recognitions & Rankings of Cyto-Sure
Contact details
Cyto-Sure Private Limited's registered office is in Bangalore, Karnataka. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressNo.1796 21st Cross C Block 5th Main Sahakaranagar, Bangalore, Karnataka, India – 560092
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Cyto-Sure Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Cyto-Sure is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Cyto-Sure Private Limited, buy the company report.
Financials of Cyto-Sure Private Limited
FY 2022 filings availableCyto-Sure Private Limited reported revenue of ₹35,400 for FY 2022.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹43,900 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹43,900 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -124% | |||
| Net Profit Margin | -124% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Cyto-Sure Private Limited, buy the company report.
Board of directors of Cyto-Sure Private Limited
Cyto-Sure has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gopal Sudershan Reddy Also directs: Clinivio Health Care Private Limited | Director | 26 Dec 2018 | 7 Years 10 Months | Current |
| Kalavati Sudershan Reddy | Director | 10 Oct 2019 | 7 Years 0 Months | Current |
Peer comparison
Cyto-Sure Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Contract Research), with the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Oshni Medicines Research and Development Organization Private Limited | ₹43,500 (FY 2025) | -89.0% | Namakkal, Tamil Nadu, India | |||
| Novita Healthntech Private Limited | ₹40,389 (FY 2023) | 8.0% | Hyderabad, Telangana, India | |||
| Cyto-Sure Private Limitedthis company | ₹35,400 (FY 2022) | -₹43,900 | -124% | Bangalore, Karnataka, India | ||
| Dhathri Ayurveda Hospitals and Researches Private Limited | ₹33,300 (FY 2025) | Ernakulam, Kerala, India |
To see the full peer comparison of Cyto-Sure Private Limited, buy the company report.
Auditor
Cyto-Sure Private Limited is audited by MOHAN & CHANDRASEKHAR for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MOHAN & CHANDRASEKHAR | FY 2019 | 009148S |
Shareholding
The shareholding of Cyto-Sure Private Limited is on record for FY 2019, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2019 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Cyto-Sure Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Nov 2022 | 100656226 | Canara Bank | ₹23 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Cyto-Sure Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cyto-Sure Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Cyto-Sure has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAHCC9291P1ZN | Karnataka | Active | 05 Feb 2019 |
To see the full GST registrations and return filing status of Cyto-Sure Private Limited, buy the company report.
Recent activity
Cyto-Sure Private Limited has 3 board changes on record since 2018: 2 appointments and 1 cessation. The latest: Kalavati Sudershan Reddy was appointed as Director on 10 Oct 2019.
Frequently asked questions
Cyto-Sure is an active private limited company based in Bangalore, Karnataka, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 26 December 2018 (8+ years old) and is registered under CIN U85300KA2018PTC119784.
Cyto-Sure has 2 current directors:
- Gopal Sudershan Reddy - Director
- Kalavati Sudershan Reddy - Director
The latest financial statements of Cyto-Sure on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Cyto-Sure is 29AAHCC9291P1ZN, registered in Karnataka.
The CIN (Corporate Identification Number) of Cyto-Sure is U85300KA2018PTC119784. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cyto-Sure was incorporated on 26 December 2018, making it 8+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Cyto-Sure by revenue are Oshni Medicines Research and Development Organization Private Limited, Novita Healthntech Private Limited, Dhathri Ayurveda Hospitals and Researches Private Limited, all in the Pharma industry (Contract Research), with the same principal business activity (other hospital and medical care activities).
Kalavati Sudershan Reddy was appointed as Director on 10 Oct 2019. Sanjaya Kumar Mallick ceased to be Director on 10 Oct 2019. Gopal Sudershan Reddy was appointed as Director on 26 Dec 2018.
Yes, Cyto-Sure is registered as a micro enterprise under Udyam registration (number: UDYAM-KR-03-0212737).
The registered office of Cyto-Sure is at No.1796 21st Cross C Block 5th Main Sahakaranagar, Bangalore, Karnataka, India – 560092.
Cyto-Sure operates in the pharma industry, in the pharma contract r and d segment.

